Lukasz Biernat is a Primary Care physician affiliated with Eli Lilly. OpenAlex indexes 12 publications with 228 citations (h-index 7); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
Sponsor: LB Pharmaceuticals Inc.
- Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation
Sponsor: Ligand Pharmaceuticals
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Matthay, MD
University of California San Francisco
Elaine Hylek, MD
Boston University Chobanian and Avedisian School of Medicine
Wilbert Aronow, MD
Westchester Medical Center
David Mannino, MD
University of Kentucky
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”